Trial Profile
A Double Blind, Placebo Controlled Randomized Trial Evaluating the Effects of Fluticasone Nasal Spray in Subjects With Seasonal Allergic Rhinitis and a History of Sleep Disturbance on Cognitive Performance and Daytime Sleepiness.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Sep 2023
Price :
$35
*
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- 27 Jun 2012 Additional trial location (USA) added as reported by ClinicalTrials.gov.
- 27 Jun 2012 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 23 Sep 2010 Actual initiation date added to 1 Mar 2010 as reported by ClinicalTrials.gov.